Drug Trial Radar · NCT02437981
Evaluation of PrEP-30: a Demonstration Project of Pre-exposure Prophylaxis for MSM and Other High-risk Group Clients at the Thai Red Cross Anonymous Clinic
Last checked: Nov 19, 2026Latest source record: Nov 25, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
20,000
Planned (sponsor's estimate)
Start
Dec 2014
Primary completion
Dec 2024
Study completion Jan 2027
Sponsor
- Lead sponsor
- Thai Red Cross AIDS Research CentreAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 8, 2015
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
PrEP-30 is a demonstration project to assess the feasibility of providing oral PrEP to MSM and other individuals at-risk for HIV in Bangkok, Thailand as a service that is funded entirely through user fees. Tenofovir disoproxil fumarate/emtricitabine PrEP is provided part of a combined HIV prevention program that includes risk-reduction counseling, regular HIV testing, and the provision of condoms and lubricants. PrEP-30 is implemented at the Thai Red Cross AIDS Research Centre, at the site of the largest HIV counseling and testing center in Thailand.
Conditions
- HIV Prevention
Interventions
PrEPDrug
Oral pre-exposure prophylaxis (PrEP) for HIV infection using a daily combination tablet of tenofovir disoproxil fumarate and emtricitabine
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary outcome measures:Time frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Thai Red Cross AIDS Research Centre
Bangkok, Pathumwan, Thailand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.